BUSERELIN (SuprecurĀ®)

Clinical Indication



Regulation restricts the prescribing and supply of puberty-suppressing hormones to children and young people under 18

The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Emergency Prohibition) (England, Wales and Scotland) Order 2024 (legislation.gov.uk)Ā 

Date of classification

June 2024


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.